| PC | Prostate cancer |
| 3βHSD1 | 3β-Hydroxysteroid dehydrogenase type 1 |
| DHEA | Dehydroepiandrosterone |
| DHT | Dihydrotestosterone |
| mCRPC | Metastatic castration-resistant prostate cancer |
| AR | Androgen receptor |
| ADT | Androgen depravation therapy |
| OS | Overall survival |
| ICI | Immune checkpoint inhibitor |
| ER | Estrogen receptor |